DWM
AZN icon

Defined Wealth Management’s AstraZeneca AZN Stock Holding History

Defined Wealth Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$245K Buy
1,293
+1
+0.1% +$188 0.13% 108
2026
Q1 		$255K Buy
1,292
+9
+0.7% +$1.74K 0.15% 99
2025
Q4 		$236K Buy
+1,283
New +$225K 0.14% 107

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Defined Wealth Management's AZN Position: Q2 2026 in Review

Defined Wealth Management increased its AstraZeneca (AZN) stake by 0.08% in Q2 2026, buying an estimated $188 and bringing the position to 1,293 shares worth $245K. The position accounts for 0.13% of the portfolio, ranked #108.

Defined Wealth Management first reported a position in AZN in Q4 2025 and has held it in 3 quarters since. The position peaked at $255K in Q1 2026. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Defined Wealth Management held 1,293 shares of AstraZeneca worth $245K as of Q2 2026.
  • Defined Wealth Management bought 1 AstraZeneca share in Q2 2026, an estimated $188.
  • AstraZeneca made up 0.13% of Defined Wealth Management's portfolio in Q2 2026, its #108 holding.
  • Defined Wealth Management first reported a position in AstraZeneca in Q4 2025 and has held it in 3 quarters since.
  • Defined Wealth Management's AstraZeneca position peaked at $255K in Q1 2026.
  • 1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Defined Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.